• 1. Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2
  Francesco Marchetti,Kerry L. Sayle,Johanne Bentley,William Clegg,Nicola J. Curtin,Jane A. Endicott,Bernard T. Golding,Roger J. Griffin,Karen Haggerty,Ross W. Harrington,Veronique Mesguiche,David R. Newell,Martin E. M. Noble,Rachel J. Parsons,David J. Pratt,Lan Z. Wang,Ian R. Hardcastle Org. Biomol. Chem. 2007 5 1577

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Professional Introduction to 4-amino-N,N-dimethylbenzene-1-sulfonamide (CAS No. 1709-59-7)

4-amino-N,N-dimethylbenzene-1-sulfonamide, identified by the chemical abstracts service number CAS No. 1709-59-7, is a sulfonamide derivative with significant applications in pharmaceutical and chemical research. This compound, featuring a benzene ring substituted with an amino group at the 4-position and N,N-dimethylamino groups at the 1 and 3 positions, has garnered attention due to its structural versatility and potential biological activity. The sulfonamide moiety is particularly noteworthy, as it is a well-established pharmacophore in medicinal chemistry, contributing to the development of drugs with diverse therapeutic effects.

The synthesis of 4-amino-N,N-dimethylbenzene-1-sulfonamide involves multi-step organic transformations, typically starting from benzene or its derivatives. The introduction of the sulfonamide group requires careful control of reaction conditions to ensure high yield and purity. Modern synthetic methodologies often employ catalytic processes or transition metal complexes to enhance efficiency and minimize byproduct formation. The dimethylation at the nitrogen atoms introduces steric hindrance, which can influence the compound's solubility and interaction with biological targets.

Recent research has highlighted the potential of sulfonamide derivatives as modulators of enzyme activity and receptor binding. Specifically, 4-amino-N,N-dimethylbenzene-1-sulfonamide has been investigated for its interactions with bacterial enzymes, particularly those involved in metabolic pathways that are critical for bacterial survival. Studies suggest that this compound may exhibit inhibitory effects on certain bacterial species by disrupting key enzymatic processes. This finding aligns with the broader trend in antibiotic development, where sulfonamides continue to be explored as alternatives or adjuncts to conventional antibiotics.

In addition to its antimicrobial potential, 4-amino-N,N-dimethylbenzene-1-sulfonamide has shown promise in other therapeutic areas. Its structural framework allows for modifications that can enhance binding affinity to specific biological targets, making it a valuable scaffold for drug discovery. Researchers have utilized computational modeling to predict how variations in the substitution pattern of this compound might affect its pharmacokinetic properties. These studies underscore the importance of structure-activity relationships (SAR) in optimizing sulfonamide-based drugs for clinical use.

The role of CAS No. 1709-59-7 in academic and industrial research cannot be overstated. Its availability as a reference compound enables scientists to conduct comparative studies and validate synthetic routes. The compound's stability under various storage conditions also makes it suitable for long-term research projects. As interest in personalized medicine grows, compounds like 4-amino-N,N-dimethylbenzene-1-sulfonamide are being evaluated for their potential use in tailored therapeutic strategies.

From a regulatory perspective, 4-amino-N,N-dimethylbenzene-1-sulfonamide is subject to standard guidelines for chemical handling and documentation. While it is not classified as a hazardous or controlled substance under current regulations, adherence to safety protocols is essential when working with organic compounds in laboratory settings. Proper documentation ensures compliance with Good Manufacturing Practices (GMP) and facilitates collaboration across international research teams.

The future of 4-amino-N,N-dimethylbenzene-1-sulfonamide lies in its adaptability for further derivatization and application across multiple domains. Advances in synthetic chemistry and biotechnology continue to open new avenues for its use, from developing novel therapeutics to serving as intermediates in more complex molecules. As research progresses, the compound's role in addressing global health challenges is likely to expand, reinforcing its significance in modern chemical biology.

• 459434-40-3(3-amino-N-methylbenzene-1-sulfonamide)
• 57824-30-3(3,4-diamino-N,N-dimethylbenzene-1-sulfonamide)
• 61509-78-2(2-Naphthalenesulfonamide, N,N-dimethyl-6-(phenylamino)-)
• 14417-01-7(N,N-Dimethylbenzenesulfonamide)
• 137473-37-1(N-Methyl-4-(methylamino)benzene-1-sulfonamide)
• 104295-55-8(2-Naphthylamine-6-sulfomethylamide)
• 1709-52-0(4-amino-N-methylbenzene-1-sulfonamide)
• 54468-86-9(2-amino-N,N-dimethyl-benzenesulfonamide)
• 1214-03-5(1-Naphthalenesulfonamide,6-amino-N,N-dimethyl-)
• 6274-18-6(3-Amino-n,n-dimethylbenzenesulfonamide)